Suchergebnisse - "Shi, Yuankai"

PubPharm (24)

1

Identification of novel serological autoantibodies in Chinese prostate cancer patients using high-throughput protein arrays

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Lou, N. | Zheng, C. | Wang, Y. | +7

2

The Feasibility of Using Biomarkers Derived from Circulating Tumor DNA Sequencing as Predictive Classifiers in Patients with Small-Cell Lung Cancer

enthalten in: Cancer research and treatment | 2022

von Feng, Y. | Liu, Y. | Yuan, M. | +12

3

High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes

enthalten in: Cancer science | 2022

von Luo, R. | Zheng, C. | Song, W. | +3

4

The impact of the ALK fusion variant on clinical outcomes in EML4-ALK patients with NSCLC : a systematic review and meta-analysis

enthalten in: Future oncology (London, England) | 2022

von Wang, S. | Luo, R. | Shi, Y. | +1

5

Cytokines screening identifies MIG (CXCL9) for postoperative recurrence prediction in operated non-small cell lung cancer patients

enthalten in: Cytokine | 2022

von Zhang, N. | Tan, Q. | Tao, D. | +9

6

High PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor in urothelial carcinoma

enthalten in: Future oncology (London, England) | 2021

von Zhong, Q. | Shou, J. | Ying, J. | +7

7

Meta-analysis of the prognostic and clinical value of serum 25-hydroxyvitamin D levels in previously untreated lymphoma

enthalten in: Future oncology (London, England) | 2021

von Tao, Y. | Chen, H. | Zhou, Y. | +1

8

Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M-positive Non-Small Cell Lung Cancer and Central Nervous System Metastases : The APOLLO Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Xing, L. | Pan, Y. | Shi, Y. | +16

CommentIn: Clin Cancer Res. 2020 Dec 1;26(23):6077-6079. - PMID 32998958

9

Advances in Drug Resistance Mechanisms and Prognostic Markers of Targeted Therapy in ALK-positive Non-small Cell Lung Cancer

enthalten in: Zhongguo fei ai za zhi = Chinese journal of lung cancer | 2020

von Wang, S. | Shi, Y. | Han, X.

10

Molecular profiling of Chinese R-CHOP treated DLBCL patients : Identifying a high-risk subgroup

enthalten in: International journal of cancer | 2020

von Jiang, S. | Qin, Y. | Jiang, H. | +13